Table 2.
n = 82 | B | Std. Error | 95%CI | p |
---|---|---|---|---|
Clinical parameter | ||||
Age | − 0.06 | 0.04 | − 1.45–8.95 | 0.101 |
PSA | 0.05 | 0.02 | 0.01–0.10 | 0.032 |
PSAD | 3.93 | 1.29 | 1.63–6.74 | 0.002 |
Biopsy parameter | ||||
ISUP GG | 0.85 | 0.33 | 0.22–1.54 | 0.011 |
Infiltration | 0.03 | 0.01 | 0.01–0.06 | 0.002 |
MRI parameter | ||||
Localization | 1.61 | 0.62 | 0.42–2.90 | 0.010 |
Diameter | 0.04 | 0.03 | − 0.01–0.10 | 0.142 |
ADC value | − 0.002 | 0.001 | − 0.01–0.01 | 0.170 |
MRI T stage | 2.04 | 0.57 | 0.99–3.26 | <0.001 |
LCC | 0.06 | 0.02 | 0.02–0.11 | 0.005 |
MRI magnetic resonance imaging, PSA prostate-specific antigen, PSAD prostate-specific antigen density, ISUP International Society of Urological Pathology, GG grade group, ADC apparent diffusion, T stage Tumor stage, LCC length to prostatic pseudocapsule, B estimation coefficient, Std. Error standard error, CI confidence interval, p p-value
p-values <0.05 are given as statistically significant